Cite
MLA Citation
J F Colombel et al.. “P573 The safety profile of upadacitinib maintenance therapy in ulcerative colitis in the Phase 3 U-ACHIEVE study is consistent with that in approved indications.” Journal of Crohn's and colitis, vol. 16, n.d., p. i514. http://access.bl.uk/ark:/81055/vdc_100150514992.0x000018